NISHIMURA, R., ARIMA, N., TOYOSHIMA, S., OHI, Y., ANAN, K., SAGARA, Y., . . . TAMURA, K. (2013). Evaluation of PTEN loss and PIK3CA mutations and their correlation with efficacy of trastuzumab treatment in HER2-positive metastatic breast cancer: A retrospective study (KBC-SG 1001). D.A. Spandidos.
Chicago Style CitationNISHIMURA, REIKI, NOBUYUKI ARIMA, SATOSHI TOYOSHIMA, YASUYO OHI, KEISEI ANAN, YASUAKI SAGARA, SHOSHU MITSUYAMA, i KAZUO TAMURA. Evaluation of PTEN Loss and PIK3CA Mutations and Their Correlation With Efficacy of Trastuzumab Treatment in HER2-positive Metastatic Breast Cancer: A Retrospective Study (KBC-SG 1001). D.A. Spandidos, 2013.
Cita MLANISHIMURA, REIKI, et al. Evaluation of PTEN Loss and PIK3CA Mutations and Their Correlation With Efficacy of Trastuzumab Treatment in HER2-positive Metastatic Breast Cancer: A Retrospective Study (KBC-SG 1001). D.A. Spandidos, 2013.